세계의 메디컬 라이팅 분야 인공지능(AI) 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별 전망 및 예측(2024-2031년)

The Global AI In Medical Writing Market size is expected to reach $1.72 billion by 2031, rising at a market growth of 12.2% CAGR during the forecast period.

Canada is also embracing AI in medical writing as part of its broader investment in healthcare, which reached approximately CAD 331 billion in 2022, according to the Canadian Institute for Health Information (CIHI). Government initiatives like the "Canada Health Infoway" aim to enhance healthcare delivery through digital solutions, emphasizing personalized medicine that tailors treatments to individual patients. Thus, The North America segment garnered 35% revenue share in the market in 2023.

Adherence to stringent regulatory requirements is paramount in the pharmaceutical and healthcare industries. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others mandate detailed and accurate documentation for every stage of drug development, clinical trials, manufacturing, and post-market surveillance. Hence, the increasing need for regulatory compliance in the pharmaceutical and healthcare sectors has driven the adoption of AI-powered solutions.

Additionally, the global expansion of clinical trials drives the need for detailed and accurate documentation, including protocols, trial results, and regulatory submissions. As clinical trials become more complex and widespread, especially in emerging markets, the volume of data generated has significantly increased.

However, the integration of AI-powered solutions into medical writing processes comes with substantial financial requirements. These costs include developing sophisticated AI algorithms, acquiring robust computing infrastructure, and ongoing maintenance. Additionally, companies must often invest in hiring or training skilled personnel to manage and optimize these systems effectively. As a result, many SMEs rely on traditional methods, missing out on the potential efficiency and accuracy gains offered by AI-driven systems. Therefore, such expansion has underscored the importance of precise and efficient documentation, driving the demand for AI in medical writing solutions.

Type Outlook

Based on type, the market is classified into clinical writing, type writing, scientific writing, and others. The scientific writing segment procured 27% revenue share in the market in 2023. This segment is advantageous due to the increasing demand for high-quality, data-driven medical research and scholarly content.

End Use Outlook

On the basis of end use, the market is divided into medical devices, pharmaceutical, biotechnology, and others. The pharmaceutical segment acquired 32% revenue share in the market in 2023. The pharmaceutical segment is primarily driven by the rising demand for regulatory compliance and the need to manage extensive documentation for clinical trials, drug development, and safety reporting.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed 28% revenue share in the market in 2023. The Asia-Pacific region is being propelled by the swift growth of the pharmaceutical and healthcare sectors, especially in developing countries like China, India, and Japan.

List of Key Companies Profiled

• Parexel International (MA) Corporation
• Certara, Inc.
• Accenture PLC
• Smarter Dx, Inc.
• Corti ApS
• IQVIA Holdings, Inc.
• Abridge Al, Inc.
• Syneos Health, Inc.
• IBM Corporation
• Teladoc Health, Inc.

Global AI In Medical Writing Market Report Segmentation

By Type

• Type Writing
• Scientific Writing
• Clinical Writing
• Other Type

By End Use

• Pharmaceutical
• Biotechnology
• Medical Devices
• Other End Use

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global AI In Medical Writing Market, by Type
  • 1.4.2 Global AI In Medical Writing Market, by End Use
  • 1.4.3 Global AI In Medical Writing Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 Market Share Analysis, 2023
• 4.2 Recent Strategies Deployed in AI In Medical Writing Market
• 4.3 Porter Five Forces Analysis

Chapter 5. Global AI In Medical Writing Market by Type

• 5.1 Global Type Writing Market by Region
• 5.2 Global Scientific Writing Market by Region
• 5.3 Global Clinical Writing Market by Region
• 5.4 Global Other Type Market by Region

Chapter 6. Global AI In Medical Writing Market by End Use

• 6.1 Global Pharmaceutical Market by Region
• 6.2 Global Biotechnology Market by Region
• 6.3 Global Medical Devices Market by Region
• 6.4 Global Other End Use Market by Region

Chapter 7. Global AI In Medical Writing Market by Region

• 7.1 North America AI In Medical Writing Market
  • 7.1.1 North America AI In Medical Writing Market by Type
    • 7.1.1.1 North America Type Writing Market by Country
    • 7.1.1.2 North America Scientific Writing Market by Country
    • 7.1.1.3 North America Clinical Writing Market by Country
    • 7.1.1.4 North America Other Type Market by Country
  • 7.1.2 North America AI In Medical Writing Market by End Use
    • 7.1.2.1 North America Pharmaceutical Market by Country
    • 7.1.2.2 North America Biotechnology Market by Country
    • 7.1.2.3 North America Medical Devices Market by Country
    • 7.1.2.4 North America Other End Use Market by Country
  • 7.1.3 North America AI In Medical Writing Market by Country
    • 7.1.3.1 US AI In Medical Writing Market
      • 7.1.3.1.1 US AI In Medical Writing Market by Type
      • 7.1.3.1.2 US AI In Medical Writing Market by End Use
    • 7.1.3.2 Canada AI In Medical Writing Market
      • 7.1.3.2.1 Canada AI In Medical Writing Market by Type
      • 7.1.3.2.2 Canada AI In Medical Writing Market by End Use
    • 7.1.3.3 Mexico AI In Medical Writing Market
      • 7.1.3.3.1 Mexico AI In Medical Writing Market by Type
      • 7.1.3.3.2 Mexico AI In Medical Writing Market by End Use
    • 7.1.3.4 Rest of North America AI In Medical Writing Market
      • 7.1.3.4.1 Rest of North America AI In Medical Writing Market by Type
      • 7.1.3.4.2 Rest of North America AI In Medical Writing Market by End Use
• 7.2 Europe AI In Medical Writing Market
  • 7.2.1 Europe AI In Medical Writing Market by Type
    • 7.2.1.1 Europe Type Writing Market by Country
    • 7.2.1.2 Europe Scientific Writing Market by Country
    • 7.2.1.3 Europe Clinical Writing Market by Country
    • 7.2.1.4 Europe Other Type Market by Country
  • 7.2.2 Europe AI In Medical Writing Market by End Use
    • 7.2.2.1 Europe Pharmaceutical Market by Country
    • 7.2.2.2 Europe Biotechnology Market by Country
    • 7.2.2.3 Europe Medical Devices Market by Country
    • 7.2.2.4 Europe Other End Use Market by Country
  • 7.2.3 Europe AI In Medical Writing Market by Country
    • 7.2.3.1 Germany AI In Medical Writing Market
      • 7.2.3.1.1 Germany AI In Medical Writing Market by Type
      • 7.2.3.1.2 Germany AI In Medical Writing Market by End Use
    • 7.2.3.2 UK AI In Medical Writing Market
      • 7.2.3.2.1 UK AI In Medical Writing Market by Type
      • 7.2.3.2.2 UK AI In Medical Writing Market by End Use
    • 7.2.3.3 France AI In Medical Writing Market
      • 7.2.3.3.1 France AI In Medical Writing Market by Type
      • 7.2.3.3.2 France AI In Medical Writing Market by End Use
    • 7.2.3.4 Russia AI In Medical Writing Market
      • 7.2.3.4.1 Russia AI In Medical Writing Market by Type
      • 7.2.3.4.2 Russia AI In Medical Writing Market by End Use
    • 7.2.3.5 Spain AI In Medical Writing Market
      • 7.2.3.5.1 Spain AI In Medical Writing Market by Type
      • 7.2.3.5.2 Spain AI In Medical Writing Market by End Use
    • 7.2.3.6 Italy AI In Medical Writing Market
      • 7.2.3.6.1 Italy AI In Medical Writing Market by Type
      • 7.2.3.6.2 Italy AI In Medical Writing Market by End Use
    • 7.2.3.7 Rest of Europe AI In Medical Writing Market
      • 7.2.3.7.1 Rest of Europe AI In Medical Writing Market by Type
      • 7.2.3.7.2 Rest of Europe AI In Medical Writing Market by End Use
• 7.3 Asia Pacific AI In Medical Writing Market
  • 7.3.1 Asia Pacific AI In Medical Writing Market by Type
    • 7.3.1.1 Asia Pacific Type Writing Market by Country
    • 7.3.1.2 Asia Pacific Scientific Writing Market by Country
    • 7.3.1.3 Asia Pacific Clinical Writing Market by Country
    • 7.3.1.4 Asia Pacific Other Type Market by Country
  • 7.3.2 Asia Pacific AI In Medical Writing Market by End Use
    • 7.3.2.1 Asia Pacific Pharmaceutical Market by Country
    • 7.3.2.2 Asia Pacific Biotechnology Market by Country
    • 7.3.2.3 Asia Pacific Medical Devices Market by Country
    • 7.3.2.4 Asia Pacific Other End Use Market by Country
  • 7.3.3 Asia Pacific AI In Medical Writing Market by Country
    • 7.3.3.1 China AI In Medical Writing Market
      • 7.3.3.1.1 China AI In Medical Writing Market by Type
      • 7.3.3.1.2 China AI In Medical Writing Market by End Use
    • 7.3.3.2 Japan AI In Medical Writing Market
      • 7.3.3.2.1 Japan AI In Medical Writing Market by Type
      • 7.3.3.2.2 Japan AI In Medical Writing Market by End Use
    • 7.3.3.3 India AI In Medical Writing Market
      • 7.3.3.3.1 India AI In Medical Writing Market by Type
      • 7.3.3.3.2 India AI In Medical Writing Market by End Use
    • 7.3.3.4 South Korea AI In Medical Writing Market
      • 7.3.3.4.1 South Korea AI In Medical Writing Market by Type
      • 7.3.3.4.2 South Korea AI In Medical Writing Market by End Use
    • 7.3.3.5 Singapore AI In Medical Writing Market
      • 7.3.3.5.1 Singapore AI In Medical Writing Market by Type
      • 7.3.3.5.2 Singapore AI In Medical Writing Market by End Use
    • 7.3.3.6 Malaysia AI In Medical Writing Market
      • 7.3.3.6.1 Malaysia AI In Medical Writing Market by Type
      • 7.3.3.6.2 Malaysia AI In Medical Writing Market by End Use
    • 7.3.3.7 Rest of Asia Pacific AI In Medical Writing Market
      • 7.3.3.7.1 Rest of Asia Pacific AI In Medical Writing Market by Type
      • 7.3.3.7.2 Rest of Asia Pacific AI In Medical Writing Market by End Use
• 7.4 LAMEA AI In Medical Writing Market
  • 7.4.1 LAMEA AI In Medical Writing Market by Type
    • 7.4.1.1 LAMEA Type Writing Market by Country
    • 7.4.1.2 LAMEA Scientific Writing Market by Country
    • 7.4.1.3 LAMEA Clinical Writing Market by Country
    • 7.4.1.4 LAMEA Other Type Market by Country
  • 7.4.2 LAMEA AI In Medical Writing Market by End Use
    • 7.4.2.1 LAMEA Pharmaceutical Market by Country
    • 7.4.2.2 LAMEA Biotechnology Market by Country
    • 7.4.2.3 LAMEA Medical Devices Market by Country
    • 7.4.2.4 LAMEA Other End Use Market by Country
  • 7.4.3 LAMEA AI In Medical Writing Market by Country
    • 7.4.3.1 Brazil AI In Medical Writing Market
      • 7.4.3.1.1 Brazil AI In Medical Writing Market by Type
      • 7.4.3.1.2 Brazil AI In Medical Writing Market by End Use
    • 7.4.3.2 Argentina AI In Medical Writing Market
      • 7.4.3.2.1 Argentina AI In Medical Writing Market by Type
      • 7.4.3.2.2 Argentina AI In Medical Writing Market by End Use
    • 7.4.3.3 UAE AI In Medical Writing Market
      • 7.4.3.3.1 UAE AI In Medical Writing Market by Type
      • 7.4.3.3.2 UAE AI In Medical Writing Market by End Use
    • 7.4.3.4 Saudi Arabia AI In Medical Writing Market
      • 7.4.3.4.1 Saudi Arabia AI In Medical Writing Market by Type
      • 7.4.3.4.2 Saudi Arabia AI In Medical Writing Market by End Use
    • 7.4.3.5 South Africa AI In Medical Writing Market
      • 7.4.3.5.1 South Africa AI In Medical Writing Market by Type
      • 7.4.3.5.2 South Africa AI In Medical Writing Market by End Use
    • 7.4.3.6 Nigeria AI In Medical Writing Market
      • 7.4.3.6.1 Nigeria AI In Medical Writing Market by Type
      • 7.4.3.6.2 Nigeria AI In Medical Writing Market by End Use
    • 7.4.3.7 Rest of LAMEA AI In Medical Writing Market
      • 7.4.3.7.1 Rest of LAMEA AI In Medical Writing Market by Type
      • 7.4.3.7.2 Rest of LAMEA AI In Medical Writing Market by End Use

Chapter 8. Company Profiles

• 8.1 Parexel International (MA) Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Recent strategies and developments:
    • 8.1.2.1 Partnerships, Collaborations, and Agreements:
  • 8.1.3 SWOT Analysis
• 8.2 Certara, Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Regional Analysis
  • 8.2.4 Research & Development Expenses
  • 8.2.5 Recent strategies and developments:
    • 8.2.5.1 Product Launches and Product Expansions:
    • 8.2.5.2 Acquisition and Mergers:
  • 8.2.6 SWOT Analysis
• 8.3 Accenture PLC
  • 8.3.1 Company Overview
  • 8.3.2 Financial Analysis
  • 8.3.3 Segmental Analysis
  • 8.3.4 Research & Development Expenses
  • 8.3.5 SWOT Analysis
• 8.4 Smarter Dx, Inc.
  • 8.4.1 Company Overview
• 8.5 Corti ApS
  • 8.5.1 Company Overview
  • 8.5.2 SWOT Analysis
• 8.6 IQVIA Holdings, Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Segmental and Regional Analysis
  • 8.6.4 SWOT Analysis
• 8.7 Abridge Al, Inc.
  • 8.7.1 Company Overview
  • 8.7.2 Recent strategies and developments:
    • 8.7.2.1 Partnerships, Collaborations, and Agreements:
• 8.8 Syneos Health, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Financial Analysis
  • 8.8.3 Segmental and Regional Analysis
  • 8.8.4 Recent strategies and developments:
    • 8.8.4.1 Partnerships, Collaborations, and Agreements:
• 8.9 IBM Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Financial Analysis
  • 8.9.3 Regional & Segmental Analysis
  • 8.9.4 Research & Development Expenses
  • 8.9.5 SWOT Analysis
• 8.10. Teladoc Health, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 Regional Analysis
  • 8.10.4 Research & Development Expenses
  • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives of AI In Medical Writing Market